NewcelX Ltd. (NCEL)

CH — Healthcare Sector
Peers: OCEA  BACK  PRE  SRZN  CERO  SABS  BCTXW  NUWE  CELU  KTTA 

Automate Your Wheel Strategy on NCEL

With Tiblio's Option Bot, you can configure your own wheel strategy including NCEL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol NCEL
  • Rev/Share 0.0
  • Book/Share 7.1975
  • PB 0.3473
  • Debt/Equity 0.0
  • CurrentRatio 2.7736
  • ROIC -1.4244

 

  • MktCap 1125000.0
  • FreeCF/Share -12.0231
  • PFCF -0.2336
  • PE -0.4623
  • Debt/Assets 0.0
  • DivYield 0
  • ROE -1.0099

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 4
  • P/B Score 2
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About NewcelX Ltd. (NCEL)

  • IPO Date 2025-10-24
  • Website https://www.newcelx.com
  • Industry Biotechnology
  • CEO Ronen Twito
  • Employees 11
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.